Australian research projects progress with new 2022 funding

04 March 2022

MSWA is the leading contributor to neurological research in WA, and the leading state contributor to MS Australia (MSA), supporting MS research right across Australia and overseas.

MSWA Strategic Supports & Residential Options General Manager, Sue Shapland, works closely with the Research Committee of MSWA’s Board to recommend where and how MSWA’s research funds are allocated, including a range of projects managed through MSA. Ms Shapland explained MSA’s role is to evaluate applications and allocate the funding to the most deserving multiple sclerosis (MS) projects.

MSWA has a long and proud history of contributing increasing levels of funds to support MS research and over recent years for broader neurological research efforts as well.

"Research into the causes, potential cures and better treatments for many of these conditions provides hope and also translates into therapy options which can lead to better outcomes for so many", said Shapland. "We support a number of quality researchers and their WA projects through our relationships with key local institutions as well as supporting both Australian and overseas MS projects through MSA. This is possible through our own fundraising efforts and the generous support of our supporters and donors here in WA."

In late February MSA announced their $6.9m grants program, which included our allocation, for a range of research projects.

Some Western Australian MS research projects MSWA is currently funding through MSA include:

A nominated portion of MSWA’s funding to MSA has once more been allocated to support the International Progressive MS Alliance.

For more information about MSWA’s commitment to research, head to our Commitment to Research page.